Pro Share Advisors LLC Athersys, Inc Transaction History

Pro Share Advisors LLC

  • $36.5 Billion
  • Q2 2024

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022
SELL
$0.18 - $0.86 $7,185 - $34,332
-39,922 Closed
0 $0
Q1 2022

May 10, 2022
SELL
$0.6 - $1.06 $2,890 - $5,106
-4,817 Reduced 10.77%
39,922 $24,000
Q4 2021

Feb 08, 2022
BUY
$0.85 - $1.4 $15,720 - $25,893
18,495 Added 70.47%
44,739 $40,000
Q3 2021

Nov 12, 2021
SELL
$1.33 - $1.77 $34,457 - $45,857
-25,908 Reduced 49.68%
26,244 $35,000
Q2 2021

Aug 13, 2021
BUY
$1.41 - $1.94 $8,187 - $11,265
5,807 Added 12.53%
52,152 $75,000
Q1 2021

May 14, 2021
BUY
$1.61 - $2.77 $12,757 - $21,949
7,924 Added 20.62%
46,345 $83,000
Q4 2020

Feb 09, 2021
BUY
$1.55 - $2.24 $26,598 - $38,438
17,160 Added 80.71%
38,421 $67,000
Q3 2020

Nov 13, 2020
SELL
$1.91 - $3.08 $4,412 - $7,114
-2,310 Reduced 9.8%
21,261 $41,000
Q2 2020

Aug 03, 2020
BUY
$1.97 - $3.98 $46,434 - $93,812
23,571 New
23,571 $65,000
Q1 2020

May 15, 2020
SELL
$1.17 - $3.0 $21,241 - $54,465
-18,155 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$1.16 - $1.42 $3,814 - $4,668
3,288 Added 22.12%
18,155 $22,000
Q3 2019

Nov 12, 2019
BUY
$1.21 - $1.65 $3,050 - $4,159
2,521 Added 20.42%
14,867 $20,000
Q2 2019

Aug 13, 2019
SELL
$1.39 - $2.03 $447 - $653
-322 Reduced 2.54%
12,346 $21,000
Q1 2019

May 15, 2019
BUY
$1.39 - $1.71 $1,003 - $1,234
722 Added 6.04%
12,668 $19,000
Q4 2018

Feb 14, 2019
SELL
$1.41 - $2.16 $2,717 - $4,162
-1,927 Reduced 13.89%
11,946 $17,000
Q3 2018

Nov 14, 2018
SELL
$1.86 - $2.18 $1,979 - $2,319
-1,064 Reduced 7.12%
13,873 $29,000
Q2 2018

Aug 13, 2018
BUY
$1.76 - $2.79 $3,315 - $5,256
1,884 Added 14.43%
14,937 $29,000
Q1 2018

May 14, 2018
SELL
$1.34 - $2.03 $2,823 - $4,277
-2,107 Reduced 13.9%
13,053 $24,000
Q4 2017

Feb 14, 2018
BUY
$1.65 - $2.45 $25,014 - $37,142
15,160
15,160 $27,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email